Groupama Asset Managment »

Sarepta Therapeutics Inc. cmn shares owned by Groupama Asset Managment

Quarter-by-quarter ownership of Sarepta Therapeutics Inc. cmn shares owned by Groupama Asset Managment from 13F filings

Historical chart of Groupama Asset Managment investment in Sarepta Therapeutics Inc. cmn

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc. cmn held by Groupama Asset Managment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc. cmn by Groupama Asset Managment

Quarter filed Position value Share count Share price at filing
2023-12-31 $39k 380k 0.10

More positions owned by Groupama Asset Managment

Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Amazon (AMZN)
UnitedHealth (UNH)
NVIDIA Corporation (NVDA)
Motorola Solutions Com New (MSI)
Merck & Co (MRK)
JPMorgan Chase & Co. (JPM)
Micron Technology (MU)
Parker-Hannifin Corporation (PH)
Thermo Fisher Scientific (TMO)
Regeneron Pharmaceuticals (REGN)
Tesla Motors (TSLA)

View all positions for Groupama Asset Managment

Top funds holding Sarepta Therapeutics Inc. cmn

Jpmorgan Chase & Co
Groupama Asset Managment
Jane Street
Simplex Trading
Worth Venture Partners
Advisor Group Holdings

View all funds holding Sarepta Therapeutics Inc. cmn